首页 > 最新文献

International Journal of Pharmaceutical Quality Assurance最新文献

英文 中文
Comparative Analysis of Antibiotic Prescribing Patterns for Dental Infections: A Retrospective Study in a Dental Clinic 口腔感染抗生素处方模式的比较分析:一项牙科诊所的回顾性研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.42
Hiroj Bagde, Ashwini Dhopte
This research aimed to analyze and contrast the antibiotic prescription trends that occur in dentistry offices. for the management of dental infections. To fill out the data, each dentist enrolled in the study was asked to record antibiotics prescribed for 6 -8 months and then the records were collected. Recorded dental prescriptions for antibiotics served as the study’s source population, and the list of patients who brought their prescription cards to the dental office within the allotted window of time (January 1 to December 31, 2015) served as its sampling frame. Using a statistical technique, After selecting patient record cards that included at least one antibiotic during the course of the investigation, the appropriate size of the sample was determined. The study employed a retrospective analysis of prescribing data from 10 private dental clinics, encompassing a sample of dental infection cases and corresponding antibiotic prescriptions. Data on the type and frequency of antibiotics and patient medical history and age were collected and analyzed. Descriptive statistics and statistical tests were used to examine the relationships between antibiotic prescribing patterns and patient factors. The results revealed significant associations between medical history, patient age, and antibiotic prescribing patterns. The findings highlight the need for personalized prescribing approaches based on patient factors, standardized clinical processes, and cost-effective antibiotic choices. Improving compliance with clinical guidelines can help optimize antibiotic use and enhance patient outcomes in dental practice.
本研究旨在分析和对比抗生素处方趋势,发生在牙科诊所。用于治疗牙齿感染。为了填写数据,每位参加研究的牙医都被要求记录6 -8个月的抗生素处方,然后收集记录。记录的牙科抗生素处方作为研究的源人群,在指定的时间窗口(2015年1月1日至12月31日)内携带处方卡到牙科诊所就诊的患者名单作为研究的采样框架。使用统计技术,在调查过程中选择包括至少一种抗生素的患者记录卡后,确定适当的样本大小。该研究对10家私人牙科诊所的处方数据进行了回顾性分析,包括牙齿感染病例样本和相应的抗生素处方。收集并分析抗生素的种类和使用频率以及患者的病史和年龄。使用描述性统计和统计检验来检验抗生素处方模式与患者因素之间的关系。结果揭示了病史、患者年龄和抗生素处方模式之间的显著关联。研究结果强调了基于患者因素、标准化临床流程和具有成本效益的抗生素选择的个性化处方方法的必要性。提高临床指南的依从性可以帮助优化抗生素的使用,提高患者在牙科实践中的结果。
{"title":"Comparative Analysis of Antibiotic Prescribing Patterns for Dental Infections: A Retrospective Study in a Dental Clinic","authors":"Hiroj Bagde, Ashwini Dhopte","doi":"10.25258/ijpqa.14.3.42","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.42","url":null,"abstract":"This research aimed to analyze and contrast the antibiotic prescription trends that occur in dentistry offices. for the management of dental infections. To fill out the data, each dentist enrolled in the study was asked to record antibiotics prescribed for 6 -8 months and then the records were collected. Recorded dental prescriptions for antibiotics served as the study’s source population, and the list of patients who brought their prescription cards to the dental office within the allotted window of time (January 1 to December 31, 2015) served as its sampling frame. Using a statistical technique, After selecting patient record cards that included at least one antibiotic during the course of the investigation, the appropriate size of the sample was determined. The study employed a retrospective analysis of prescribing data from 10 private dental clinics, encompassing a sample of dental infection cases and corresponding antibiotic prescriptions. Data on the type and frequency of antibiotics and patient medical history and age were collected and analyzed. Descriptive statistics and statistical tests were used to examine the relationships between antibiotic prescribing patterns and patient factors. The results revealed significant associations between medical history, patient age, and antibiotic prescribing patterns. The findings highlight the need for personalized prescribing approaches based on patient factors, standardized clinical processes, and cost-effective antibiotic choices. Improving compliance with clinical guidelines can help optimize antibiotic use and enhance patient outcomes in dental practice.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and In-vivo Anticancer Evaluation of N-(4-oxo-2- (4-((5-aryl-1,3,4 thiadiazole-2yl) amino) Phenyl thiazolidine-3-yl) Benzamide derivative N-(4-氧-2-(4-(5-芳基-1,3,4噻二唑-2基)氨基)苯基噻唑烷-3-基)苯酰胺衍生物的合成及体内抗癌评价
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.02
Amit Chawla, Lalchand Devhare, G. Dharmamoorthy, Ritika ., Sachin Tyagi
The development of novel antitumor agents is paramount in the fight against drug resistance and its associated cardiotoxicity. The present study carried out a thorough anticancer evaluation of N- (4-oxo-2-(4-((5-aryl-1,3,4 thiadiazole-2yl) amino) phenyl thiazolidine-3-yl) benzamide (TH08) in Ehrlich ascites carcinoma (EAC) in Swiss albino mice. Our assessment included the measurement of tumor weight, the duration of survival for mice with tumors, and tumor cell growth inhibition. Additionally, we analyzed hematological parameters, like white and red blood cells and hemoglobin levels. The results we obtained clearly demonstrate that TH08 is a potent anticancer agent that exerts a positive effect on EAC cells. To determine TH08's effectiveness, We compared our findings to those achieved by using the standard medication, bleomycin. Our findings provide compelling evidence that TH08 has significant potential as a novel antitumor agent.
新型抗肿瘤药物的开发对于对抗耐药性及其相关的心脏毒性至关重要。本研究对N-(4-氧-2-(4-(5-芳基-1,3,4噻二唑-2基)氨基)苯基噻唑烷-3-基)苯甲酰胺(TH08)在瑞士白化小鼠埃利希腹水癌(EAC)中的抗癌作用进行了全面的评价。我们的评估包括肿瘤重量的测量、肿瘤小鼠的生存时间和肿瘤细胞生长抑制。此外,我们还分析了血液学参数,如白细胞、红细胞和血红蛋白水平。结果清楚地表明TH08是一种有效的抗癌剂,对EAC细胞有积极的作用。为了确定TH08的有效性,我们将我们的研究结果与使用标准药物博来霉素的结果进行了比较。我们的研究结果提供了令人信服的证据,表明TH08作为一种新型抗肿瘤药物具有显著的潜力。
{"title":"Synthesis and In-vivo Anticancer Evaluation of N-(4-oxo-2- (4-((5-aryl-1,3,4 thiadiazole-2yl) amino) Phenyl thiazolidine-3-yl) Benzamide derivative","authors":"Amit Chawla, Lalchand Devhare, G. Dharmamoorthy, Ritika ., Sachin Tyagi","doi":"10.25258/ijpqa.14.3.02","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.02","url":null,"abstract":"The development of novel antitumor agents is paramount in the fight against drug resistance and its associated cardiotoxicity. The present study carried out a thorough anticancer evaluation of N- (4-oxo-2-(4-((5-aryl-1,3,4 thiadiazole-2yl) amino) phenyl thiazolidine-3-yl) benzamide (TH08) in Ehrlich ascites carcinoma (EAC) in Swiss albino mice. Our assessment included the measurement of tumor weight, the duration of survival for mice with tumors, and tumor cell growth inhibition. Additionally, we analyzed hematological parameters, like white and red blood cells and hemoglobin levels. The results we obtained clearly demonstrate that TH08 is a potent anticancer agent that exerts a positive effect on EAC cells. To determine TH08's effectiveness, We compared our findings to those achieved by using the standard medication, bleomycin. Our findings provide compelling evidence that TH08 has significant potential as a novel antitumor agent.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confidence in Oral Cancer Awareness among Undergraduate Health Profession University Students at Al-Quds University 圣城大学卫生专业本科生口腔癌认知的信心调查
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.44
Nour Qawasmeh, Mohammad Assaf, Deniz Noyun
Background: Oral cancer is the sixth most commonly diagnosed cancer in the world. Still, awareness of this disease among undergraduate health profession university students is insufficient. Many students lack an understanding of risk factors and early signs of oral cancer. Therefore rises a need to increase awareness of oral cancer among health profession graduates so that they may be trained to recognize, diagnose, and properly manage this potentially deadly disease. Method: This study aimed to assess the current awareness and knowledge in oral cancer, focusing on prevention, early detection and adequate referral amongst undergraduate students studying a healthcare profession at Al-Quds University. This was a qualitative survey conducted among 64 senior students at various health profession undergraduate programs. The survey was distributed online and included questions about prevention, early detection, adequate referral, and overall confidence. Results: The results of the survey indicate that dental students had a higher confidence level in the subject of oral cancer than non-dental students, with the highest levels of confidence in prevention and lower levels of confidence in adequate referral. Additionally, the results suggest that a larger proportion of non-dental students showed lower confidence in the survey, and a higher proportion of dental students showed higher confidence. Conclusion: In conclusion, this survey revealed that dental students had a higher level of confidence in the areas of prevention, early detection, and overall confidence than non-dental students. Additionally, more emphasis on these aspects is recommended for all health profession students in necessary.
背景:口腔癌是世界上第六大最常见的癌症。然而,卫生专业本科学生对本病的认识不足。许多学生对口腔癌的危险因素和早期症状缺乏了解。因此,有必要提高卫生专业毕业生对口腔癌的认识,使他们能够接受培训,以识别、诊断和妥善管理这种潜在的致命疾病。方法:本研究旨在评估目前对口腔癌的认识和知识,重点是预防、早期发现和适当的转诊在圣城大学医疗保健专业的本科生中。这是一项对64名不同卫生专业本科专业高年级学生进行的定性调查。该调查在网上发布,包括有关预防、早期发现、适当转诊和总体信心的问题。结果:调查结果显示,牙科学生对口腔癌主题的信心水平高于非牙科学生,对预防的信心水平最高,对适当转诊的信心水平较低。此外,结果表明,非牙科专业的学生在调查中信心较低的比例较大,而牙科专业的学生信心较高的比例较高。结论:本调查结果显示,与非牙科学生相比,牙科学生在预防、早期发现和整体信心方面具有更高的水平。此外,建议所有卫生专业学生在必要时更多地强调这些方面。
{"title":"Confidence in Oral Cancer Awareness among Undergraduate Health Profession University Students at Al-Quds University","authors":"Nour Qawasmeh, Mohammad Assaf, Deniz Noyun","doi":"10.25258/ijpqa.14.3.44","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.44","url":null,"abstract":"Background: Oral cancer is the sixth most commonly diagnosed cancer in the world. Still, awareness of this disease among undergraduate health profession university students is insufficient. Many students lack an understanding of risk factors and early signs of oral cancer. Therefore rises a need to increase awareness of oral cancer among health profession graduates so that they may be trained to recognize, diagnose, and properly manage this potentially deadly disease. Method: This study aimed to assess the current awareness and knowledge in oral cancer, focusing on prevention, early detection and adequate referral amongst undergraduate students studying a healthcare profession at Al-Quds University. This was a qualitative survey conducted among 64 senior students at various health profession undergraduate programs. The survey was distributed online and included questions about prevention, early detection, adequate referral, and overall confidence. Results: The results of the survey indicate that dental students had a higher confidence level in the subject of oral cancer than non-dental students, with the highest levels of confidence in prevention and lower levels of confidence in adequate referral. Additionally, the results suggest that a larger proportion of non-dental students showed lower confidence in the survey, and a higher proportion of dental students showed higher confidence. Conclusion: In conclusion, this survey revealed that dental students had a higher level of confidence in the areas of prevention, early detection, and overall confidence than non-dental students. Additionally, more emphasis on these aspects is recommended for all health profession students in necessary.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypolipidemic Activity of a Polyherbal Formulation in Triton WR-1339 and High Fat Diet-induced Hyperlipidemic Rats 多草药制剂对Triton WR-1339和高脂饮食诱导的高脂血症大鼠的降血脂活性
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.39
Vishal Lad, Sufiyan Ahmad
In hyperlipidemic wistar albino rat models produced by triton and diet, the efficacy of polyherbal formulations containing four different plants was assessed. Rats exposed to Triton WR 1339 had their blood cholesterol and triglyceride levels raised. However, this was reversed when the rats were given syrup or a comparable formulation. Both formulations better lipid outlines in rats with high-fat diet-induced hyperlipidemia. Effects were marginally better with the usual medication Atrovastatin. Liver sinusoidal capillary dilations, cytoplasmic fatty infiltration, and granular degeneration were considerably reduced in polyherbal formulation-treated group II animals related with other groups. As per results, polyherbal formulations in dyslipidaemic circumstances reduce lipid levels by blocking the production of cholesterol and reducing lipid utilization.
在由triton和饮食产生的高脂血症wistar白化大鼠模型中,评估了含有四种不同植物的多草药配方的功效。暴露于Triton WR 1339的老鼠血液中的胆固醇和甘油三酯水平升高。然而,当给大鼠喂糖浆或类似的配方时,情况正好相反。两种配方对高脂肪饮食诱导的高脂血症大鼠的脂质轮廓更好。常规药物阿托伐他汀的效果略好。与其他组相比,多药复方治疗II组动物的肝窦毛细血管扩张、细胞质脂肪浸润和颗粒变性明显减少。因此,在血脂异常的情况下,多药配方通过阻断胆固醇的产生和减少脂质利用来降低脂质水平。
{"title":"Hypolipidemic Activity of a Polyherbal Formulation in Triton WR-1339 and High Fat Diet-induced Hyperlipidemic Rats","authors":"Vishal Lad, Sufiyan Ahmad","doi":"10.25258/ijpqa.14.3.39","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.39","url":null,"abstract":"In hyperlipidemic wistar albino rat models produced by triton and diet, the efficacy of polyherbal formulations containing four different plants was assessed. Rats exposed to Triton WR 1339 had their blood cholesterol and triglyceride levels raised. However, this was reversed when the rats were given syrup or a comparable formulation. Both formulations better lipid outlines in rats with high-fat diet-induced hyperlipidemia. Effects were marginally better with the usual medication Atrovastatin. Liver sinusoidal capillary dilations, cytoplasmic fatty infiltration, and granular degeneration were considerably reduced in polyherbal formulation-treated group II animals related with other groups. As per results, polyherbal formulations in dyslipidaemic circumstances reduce lipid levels by blocking the production of cholesterol and reducing lipid utilization.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resurgence of Human Monkey Pox: A Review 人类猴痘死灰复燃:综述
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.58
Shilpa Raut, Kajal Baviskar, Komal Mahajan, Shamal Dawange, Mayur Bidkar, Anjali Bedse, Harshal Tare
After being prevailing in Central and West Africa throughout the 1970s, sporadic cases of monkeypox sickness have surfaced in recent years. On the other hand, the monkey pox outbreak in the United States made headlines and garnered international attention in 2003. In 2022, the virus has caused a catastrophic pandemic, with over 50 nations being affected. There were 183 new cases of monkeypox recorded to WHO in April 2023, representing a 0.2% rise in overall cases, and 14 new deaths from the disease. Monkey pox shares the poxviridae family with the smallpox virus. One explanation for the rise of monkeypox in people is the discontinuation of smallpox immunizations. The zoonotic infectious illness is distinguished by a pustular rash resembling smallpox and systemic infection with severity ranging from mild to severe. Though the condition is self-limiting, the consequences it causes can be deadly. The illness has no particular therapy, however, it can be treated using antivirals that are effective against smallpox. Vaccines for smallpox have also been shown to be effective. The current article addresses the signs and symptoms of monkeypox sickness and the transmission pathways and treatment choices.
猴痘病在整个20世纪70年代在中非和西非流行后,近年来出现了散发病例。另一方面,2003年美国爆发的猴痘疫情成为头条新闻,引起了国际关注。2022年,该病毒引发了一场灾难性的大流行,50多个国家受到影响。2023年4月向世卫组织记录了183例猴痘新病例,代表总病例增加0.2%,并有14例新死于该疾病。猴痘与天花病毒属于痘病毒科。人类猴痘发病率上升的一个解释是停止了天花免疫接种。人畜共患传染病的特征是类似天花的脓疱疹和严重程度从轻微到严重的全身感染。虽然这种情况是自我限制的,但它引起的后果可能是致命的。这种疾病没有特别的治疗方法,但是可以使用对天花有效的抗病毒药物进行治疗。天花疫苗也被证明是有效的。本文讨论猴痘病的体征和症状以及传播途径和治疗选择。
{"title":"Resurgence of Human Monkey Pox: A Review","authors":"Shilpa Raut, Kajal Baviskar, Komal Mahajan, Shamal Dawange, Mayur Bidkar, Anjali Bedse, Harshal Tare","doi":"10.25258/ijpqa.14.3.58","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.58","url":null,"abstract":"After being prevailing in Central and West Africa throughout the 1970s, sporadic cases of monkeypox sickness have surfaced in recent years. On the other hand, the monkey pox outbreak in the United States made headlines and garnered international attention in 2003. In 2022, the virus has caused a catastrophic pandemic, with over 50 nations being affected. There were 183 new cases of monkeypox recorded to WHO in April 2023, representing a 0.2% rise in overall cases, and 14 new deaths from the disease. Monkey pox shares the poxviridae family with the smallpox virus. One explanation for the rise of monkeypox in people is the discontinuation of smallpox immunizations. The zoonotic infectious illness is distinguished by a pustular rash resembling smallpox and systemic infection with severity ranging from mild to severe. Though the condition is self-limiting, the consequences it causes can be deadly. The illness has no particular therapy, however, it can be treated using antivirals that are effective against smallpox. Vaccines for smallpox have also been shown to be effective. The current article addresses the signs and symptoms of monkeypox sickness and the transmission pathways and treatment choices.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Selegiline on Reducing Oxidative Stress in Polymorphonuclear Blood Cells (Lymphocytes) Isolated from Patients with Rheumatoid Arthritis Selegiline对类风湿关节炎患者多形核血细胞(淋巴细胞)氧化应激的影响
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.06
Purbajit Chetia, Abdul B Ahmed
Rheumatoid arthritis (RA) is a persistent condition resulting in an inflammatory response abide by the pathological mechanism of autoimmunity that causes the cartilage, bone, and joint tissues to deteriorate, lowering one’s quality of life in general. Several studies have suggested a significant association between oxidative stress caused by leukocyte-mediated inflammatory responses and the conversion of a substantial amount of oxygen into diverse free radicals, resulting in oxidative harm, including the chronic nature of rheumatoid arthritis. The utilization of DMARDs which are known as biologic and conventional disease-modifying antirheumatic drugs, has exhibited encouraging results. However, it is crucial to prioritize the discovery of novel and efficacious medications for rheumatoid arthritis in order to address the constraints associated with current therapeutic approaches. Selegiline, a synthetic drug primarily employed to manage Parkinson’s disease, predominantly interferes with the MAO-B enzyme, also known as monoamine oxidase. Additionally, it has been demonstrated to possess free radical-neutralizing properties. The goal of this study is to assess the effectiveness of selegiline in reducing oxidative stress indicators in peripheral blood mononuclear lymphocyte cells isolated from individuals diagnosed with RA. Peripheral blood was collected from 20 RA patients in accordance with the American College of Rheumatology standard. Lymphocytes were isolated following incubation with 1.5 μg/mL phorbol myristate acetate (PMA) and treatment with different concentrations (50–200 μg/mL) of selegiline. This study reveals that selegiline in concentrations of 150 and 200 μg/mL was effective enough to alleviate oxidative stress by scavenging free radicals and improving the level of natural defensive enzymes playing as antioxidants. Therefore, it can be concluded that the MAO-B inhibitor selegiline has potential as a non-toxic repurposed medicine for curtailing the pathological effects of oxidative overload during RA, unlocking the opportunity for further investigation into the impact on other inflammatory cells, such as neutrophils.
类风湿性关节炎(RA)是一种由自身免疫病理机制引起的炎症反应引起的持续性疾病,导致软骨、骨骼和关节组织恶化,总体上降低了患者的生活质量。几项研究表明,由白细胞介导的炎症反应引起的氧化应激与大量氧气转化为各种自由基之间存在显著关联,从而导致氧化损伤,包括慢性类风湿性关节炎。DMARDs是一种生物和常规的疾病缓解抗风湿药物,其应用已显示出令人鼓舞的结果。然而,重要的是要优先发现新的和有效的药物治疗类风湿性关节炎,以解决与当前治疗方法相关的限制。此外,它已被证明具有自由基中和特性。本研究的目的是评估selegiline降低RA患者外周血单核淋巴细胞氧化应激指标的有效性。按照美国风湿病学会标准采集20例RA患者外周血。分别用1.5 μg/mL肉豆蔻酸酯佛波酯(PMA)孵育和不同浓度(50 ~ 200 μg/mL)的斯来吉兰处理后分离淋巴细胞。本研究表明,浓度为150和200 μg/mL的selegiline可通过清除自由基和提高抗氧化剂的天然防御酶水平来缓解氧化应激。
{"title":"The Effect of Selegiline on Reducing Oxidative Stress in Polymorphonuclear Blood Cells (Lymphocytes) Isolated from Patients with Rheumatoid Arthritis","authors":"Purbajit Chetia, Abdul B Ahmed","doi":"10.25258/ijpqa.14.3.06","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.06","url":null,"abstract":"Rheumatoid arthritis (RA) is a persistent condition resulting in an inflammatory response abide by the pathological mechanism of autoimmunity that causes the cartilage, bone, and joint tissues to deteriorate, lowering one’s quality of life in general. Several studies have suggested a significant association between oxidative stress caused by leukocyte-mediated inflammatory responses and the conversion of a substantial amount of oxygen into diverse free radicals, resulting in oxidative harm, including the chronic nature of rheumatoid arthritis. The utilization of DMARDs which are known as biologic and conventional disease-modifying antirheumatic drugs, has exhibited encouraging results. However, it is crucial to prioritize the discovery of novel and efficacious medications for rheumatoid arthritis in order to address the constraints associated with current therapeutic approaches. Selegiline, a synthetic drug primarily employed to manage Parkinson’s disease, predominantly interferes with the MAO-B enzyme, also known as monoamine oxidase. Additionally, it has been demonstrated to possess free radical-neutralizing properties. The goal of this study is to assess the effectiveness of selegiline in reducing oxidative stress indicators in peripheral blood mononuclear lymphocyte cells isolated from individuals diagnosed with RA. Peripheral blood was collected from 20 RA patients in accordance with the American College of Rheumatology standard. Lymphocytes were isolated following incubation with 1.5 μg/mL phorbol myristate acetate (PMA) and treatment with different concentrations (50–200 μg/mL) of selegiline. This study reveals that selegiline in concentrations of 150 and 200 μg/mL was effective enough to alleviate oxidative stress by scavenging free radicals and improving the level of natural defensive enzymes playing as antioxidants. Therefore, it can be concluded that the MAO-B inhibitor selegiline has potential as a non-toxic repurposed medicine for curtailing the pathological effects of oxidative overload during RA, unlocking the opportunity for further investigation into the impact on other inflammatory cells, such as neutrophils.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemometric Assisted UV-Spectrophotometric Quantification of Cefaclor in Suspension Dosage Form 化学计量辅助紫外分光光度法定量头孢克洛混悬剂型
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.46
Kirtimaya Mishra, Budumuru Padmasri, Swetha Vegesna, Asra Jabeen, Abhilash Dash, Satyam Kumar, Diptimayee Jena
In this current study, the quality by design (QbD) concept is used for creating and validating a unique, resilient, accurate, and reliable spectrophotometric approach to quantify cefaclor (CEF) in injections. Fractional factorial design (FFD) was a design implemented to screen the initial parameters. Moreover, the variables went through the central composite design (CCD) to assess the dependency and optimize the design. Several measures were analyzed statistically to determine the appropriateness of the data obtained from the experiments. At 265 nm, by the use of ethanol, cefaclor displays an absorption maximum. Variables like screening, slit-width, and sampling interval were recognized as critical methods and again, evaluation was done by a CCD. A good linearity was produced for cefaclor in the range of 2 to 12 μg/mL, with R2>0.9993. The process was determined for being perfect, having a good average percent recovery (greater than 100%). According to ICH guidelines, validation of the developed method was performed. By implementing QbD principles, the spectrophotometric was created and designed to integrate the quality into the method. The process was manifested for being flexible and appropriate for identifying CEF in pharmaceuticals.
在当前的研究中,质量设计(QbD)概念被用于创建和验证一种独特的、弹性的、准确的、可靠的分光光度法来定量注射中的头孢克洛(CEF)。分数因子设计(FFD)是一种用于筛选初始参数的设计。并通过中心复合设计(CCD)对各变量进行相关性评估和优化设计。对几个指标进行了统计分析,以确定从实验中获得的数据的适当性。在265 nm处,使用乙醇,头孢克洛显示出最大吸收。筛选、狭缝宽度和采样间隔等变量被认为是关键方法,同样,由CCD进行评估。头孢克洛在2 ~ 12 μg/mL范围内线性良好,R2>0.9993;该工艺被认为是完美的,具有良好的平均回收率(大于100%)。根据ICH指南,对所开发的方法进行验证。通过实施QbD原理,创建并设计了分光光度法,以将质量集成到方法中。结果表明,该方法具有一定的灵活性,适合于鉴别药品中的CEF。
{"title":"Chemometric Assisted UV-Spectrophotometric Quantification of Cefaclor in Suspension Dosage Form","authors":"Kirtimaya Mishra, Budumuru Padmasri, Swetha Vegesna, Asra Jabeen, Abhilash Dash, Satyam Kumar, Diptimayee Jena","doi":"10.25258/ijpqa.14.3.46","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.46","url":null,"abstract":"In this current study, the quality by design (QbD) concept is used for creating and validating a unique, resilient, accurate, and reliable spectrophotometric approach to quantify cefaclor (CEF) in injections. Fractional factorial design (FFD) was a design implemented to screen the initial parameters. Moreover, the variables went through the central composite design (CCD) to assess the dependency and optimize the design. Several measures were analyzed statistically to determine the appropriateness of the data obtained from the experiments. At 265 nm, by the use of ethanol, cefaclor displays an absorption maximum. Variables like screening, slit-width, and sampling interval were recognized as critical methods and again, evaluation was done by a CCD. A good linearity was produced for cefaclor in the range of 2 to 12 μg/mL, with R2>0.9993. The process was determined for being perfect, having a good average percent recovery (greater than 100%). According to ICH guidelines, validation of the developed method was performed. By implementing QbD principles, the spectrophotometric was created and designed to integrate the quality into the method. The process was manifested for being flexible and appropriate for identifying CEF in pharmaceuticals.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Simple Accurate Method, Validation and It’s Degradation Studies of Nirmatrelvir, Ritonavir in Bulk and Marketed Formulation by RP-HPLC 用反相高效液相色谱法建立尼马特利韦、利托那韦原料药和市售制剂的简便、验证及降解研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.47
David Blessing Rani J, Asha Deepti C
An easy, accurate, and precise method used for simultaneous quantification of nirmatrelvir, ritonavir in bulk and marketed formulation by reverse phase high performance liquid chromatography (RP-HPLC) using a standard column Inertsil ODS (150 x 4.6 mm, 5 μm ) at a rate of flow 1-mL/min, acetonitrile and buffer containing hexane sulphonic acid, 50:50 v/v as a mobile phase was introduced through the HPLC column, detected at a wavelength 258 nm. Nirmatrelvir and ritonavir retention times were 2.481 and, 3.873 minutes, respectively. %Recovery rates for nirmatrelvir and ritonavir were 100 and 100.3%, respectively. LoD and LoQ values for nirmatrelvir and ritonavir were 1.5, 1 and 4.5, 3 g/mL, respectively. Nirmatrelvir regression equation is y = 32885.25x + 4223.04 while ritonavir is y = 39086.65x + 1680.21. Stability indicating studies done by acid, alkali, peroxide, Reduction, thermal, neutral and ultra violet light. The newly created reverse phase HPLC method, for bulk and marketed formulation, was rapid, stability indicating and accurate
采用反相高效液相色谱法(RP-HPLC),采用标准柱Inertsil ODS (150 × 4.6 mm, 5 μm),流速为1 ml /min,乙腈和含有己烷磺酸的缓冲液,以50:50 v/v为流动相,在波长258 nm检测,建立了一种简便、准确、精确的同时定量nirmatrelvir、利托那韦原料药和市售制剂的方法。尼马特瑞韦和利托那韦的滞留时间分别为2.481和3.873分钟。尼马特利韦和利托那韦的回收率分别为100%和100.3%。尼马特利韦和利托那韦的LoD和LoQ值分别为1.5、1和4.5、3 g/mL。Nirmatrelvir的回归方程为y = 32885.25x + 4223.04, ritonavir的回归方程为y = 39086.65x + 1680.21。稳定性表明在酸,碱,过氧化物,还原,热,中性和紫外光下进行的研究。新建立的反相高效液相色谱法快速、稳定、准确,适用于原料药和市售制剂
{"title":"Development of a Simple Accurate Method, Validation and It’s Degradation Studies of Nirmatrelvir, Ritonavir in Bulk and Marketed Formulation by RP-HPLC","authors":"David Blessing Rani J, Asha Deepti C","doi":"10.25258/ijpqa.14.3.47","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.47","url":null,"abstract":"An easy, accurate, and precise method used for simultaneous quantification of nirmatrelvir, ritonavir in bulk and marketed formulation by reverse phase high performance liquid chromatography (RP-HPLC) using a standard column Inertsil ODS (150 x 4.6 mm, 5 μm ) at a rate of flow 1-mL/min, acetonitrile and buffer containing hexane sulphonic acid, 50:50 v/v as a mobile phase was introduced through the HPLC column, detected at a wavelength 258 nm. Nirmatrelvir and ritonavir retention times were 2.481 and, 3.873 minutes, respectively. %Recovery rates for nirmatrelvir and ritonavir were 100 and 100.3%, respectively. LoD and LoQ values for nirmatrelvir and ritonavir were 1.5, 1 and 4.5, 3 g/mL, respectively. Nirmatrelvir regression equation is y = 32885.25x + 4223.04 while ritonavir is y = 39086.65x + 1680.21. Stability indicating studies done by acid, alkali, peroxide, Reduction, thermal, neutral and ultra violet light. The newly created reverse phase HPLC method, for bulk and marketed formulation, was rapid, stability indicating and accurate","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Materiovigilance Program for US, Europe, Japan, India and Proposed Reporting Mechanism for Indian Scenario 美国、欧洲、日本、印度的比较物质警戒计划和印度方案的拟议报告机制
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.12
Manvendra S. Teli, Vikas Jhawat
Medical devices are thought to be a blessing for the healthcare system because they are tools that can save lives. Apart from therapeutic potential, these devices have lot of negative side effects. It took a strong cohort attentive system to control such negative impacts. As a result, materiovigilance was introduced. Materiovigilance is the investigation and monitoring of incidents brought on by the use of medical devices. It controls adverse events (AE) and brings about international harmony. These goals are kept in mind when the principles, viewpoints, and materiovigilance techniques in the USA, Europe, China, Japan, Australia, Canada, and India are contrasted. It is crucial to make this comparison to comprehend the shortcomings of the current regulatory frameworks in the nations described above. Additionally, it will give the regulatory authorities a complete picture so they can alter any existing legislation as necessary. In the present study, an ideal proposed model of medical devices for its approval has been explained easily
医疗设备被认为是医疗保健系统的福音,因为它们是可以拯救生命的工具。除了治疗潜力,这些设备有很多负面的副作用。它需要一个强大的队列关注系统来控制这种负面影响。因此,引入了物质警戒。物质监察是指调查和监察因使用医疗仪器而引致的事故。它控制了不良事件,带来了国际和谐。在对比美国、欧洲、中国、日本、澳大利亚、加拿大和印度的原则、观点和物质警戒技术时,要牢记这些目标。通过这种比较来理解上述国家当前监管框架的缺点是至关重要的。此外,它将为监管机构提供一个完整的画面,以便他们可以在必要时修改任何现有的立法。在本研究中,一个理想的医疗器械的建议模型,其批准已经很容易解释
{"title":"Comparative Materiovigilance Program for US, Europe, Japan, India and Proposed Reporting Mechanism for Indian Scenario","authors":"Manvendra S. Teli, Vikas Jhawat","doi":"10.25258/ijpqa.14.3.12","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.12","url":null,"abstract":"Medical devices are thought to be a blessing for the healthcare system because they are tools that can save lives. Apart from therapeutic potential, these devices have lot of negative side effects. It took a strong cohort attentive system to control such negative impacts. As a result, materiovigilance was introduced. Materiovigilance is the investigation and monitoring of incidents brought on by the use of medical devices. It controls adverse events (AE) and brings about international harmony. These goals are kept in mind when the principles, viewpoints, and materiovigilance techniques in the USA, Europe, China, Japan, Australia, Canada, and India are contrasted. It is crucial to make this comparison to comprehend the shortcomings of the current regulatory frameworks in the nations described above. Additionally, it will give the regulatory authorities a complete picture so they can alter any existing legislation as necessary. In the present study, an ideal proposed model of medical devices for its approval has been explained easily","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemometric Exploration of Photostability of Ornidazole in Aqueous Solution with Soft and Hard Modelling Multivariate Curve Resolution Method 用软硬模型多元曲线解析法研究奥硝唑在水溶液中的光稳定性
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-09-25 DOI: 10.25258/ijpqa.14.3.27
Abhijeet Sutar, Tejas Dhole, Shruti Ringe, Shounak Kulkarni
The photodegradation study of ornidazole in an aqueous solution was performed by using the multivariate curve resolution-alternative least square technique. The sample solution was exposed to direct sunlight for 42 hours, and the spectroscopic data was obtained at predetermined intervals of wavelengths. MCR-ALS, which is a chemometric technique, was applied to the data set. Initially, soft modeling was used, followed by hard modeling. The results show that ornidazole undergoes photodegradation via a two-step process in an aqueous medium, with three species involved in the degradation process. The initial concentration of pure ornidazole decreases while the concentration of intermediate start increasing and the concentration of intermediate falls with the formation of a new product. Thus, we have got three pure spectra in the MCR-ALS process. The reaction kinetics was performed with the hard modeling technique using kinetic constrain and the rate constant of the reaction was found to be k1 = 0.0955 and k2 = 1.287, respectively.
采用多元曲线解析-替代最小二乘技术对奥硝唑在水溶液中的光降解进行了研究。将样品溶液直接暴露在阳光下42小时,并以预定的波长间隔获得光谱数据。MCR-ALS是一种化学计量技术,应用于数据集。最初,使用软建模,然后是硬建模。结果表明,奥硝唑在水介质中可通过两步法进行光降解,降解过程中有三种物质参与。纯奥硝唑初始浓度降低,中间产物浓度开始升高,中间产物浓度随着新产物的形成而下降。因此,我们在MCR-ALS过程中得到了三个纯光谱。采用动力学约束的硬模型技术进行反应动力学分析,得到反应速率常数k1 = 0.0955, k2 = 1.287。
{"title":"Chemometric Exploration of Photostability of Ornidazole in Aqueous Solution with Soft and Hard Modelling Multivariate Curve Resolution Method","authors":"Abhijeet Sutar, Tejas Dhole, Shruti Ringe, Shounak Kulkarni","doi":"10.25258/ijpqa.14.3.27","DOIUrl":"https://doi.org/10.25258/ijpqa.14.3.27","url":null,"abstract":"The photodegradation study of ornidazole in an aqueous solution was performed by using the multivariate curve resolution-alternative least square technique. The sample solution was exposed to direct sunlight for 42 hours, and the spectroscopic data was obtained at predetermined intervals of wavelengths. MCR-ALS, which is a chemometric technique, was applied to the data set. Initially, soft modeling was used, followed by hard modeling. The results show that ornidazole undergoes photodegradation via a two-step process in an aqueous medium, with three species involved in the degradation process. The initial concentration of pure ornidazole decreases while the concentration of intermediate start increasing and the concentration of intermediate falls with the formation of a new product. Thus, we have got three pure spectra in the MCR-ALS process. The reaction kinetics was performed with the hard modeling technique using kinetic constrain and the rate constant of the reaction was found to be k1 = 0.0955 and k2 = 1.287, respectively.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135867832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Pharmaceutical Quality Assurance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1